Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Merck
AstraZeneca
Express Scripts
Dow

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

Egalet Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for EGALET, and what generic and branded alternatives to EGALET drugs are available?

EGALET has four approved drugs.



Summary for Egalet
US Patents:0
Tradenames:2
Ingredients:1
NDAs:4
Patent Litigation for Egalet: See patent lawsuits for Egalet

Drugs and US Patents for Egalet

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Egalet INDOCIN indomethacin CAPSULE;ORAL 016059-002 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial
Egalet INDOCIN indomethacin CAPSULE;ORAL 016059-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial
Egalet INDOCIN indomethacin SUSPENSION;ORAL 018332-001 Oct 10, 1985 RX Yes Yes   Start Trial   Start Trial
Egalet INDOCIN indomethacin SUPPOSITORY;RECTAL 017814-001 Aug 13, 1984 DISCN Yes No   Start Trial   Start Trial
Egalet INDOCIN SR indomethacin CAPSULE, EXTENDED RELEASE;ORAL 018185-001 Feb 23, 1982 DISCN Yes No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Egalet

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Egalet INDOCIN SR indomethacin CAPSULE, EXTENDED RELEASE;ORAL 018185-001 Feb 23, 1982 4,173,626   Start Trial
Egalet INDOCIN indomethacin SUPPOSITORY;RECTAL 017814-001 Aug 13, 1984 3,644,630   Start Trial
Egalet INDOCIN indomethacin SUPPOSITORY;RECTAL 017814-001 Aug 13, 1984 3,849,549   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
McKinsey
Moodys
Medtronic
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.